Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries's GHG Emissions Data Preview
In 2024, Teva Pharmaceutical Industries completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Teva Pharmaceutical Industries has also provided a category-level breakdown for 13 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
aVerified Sources Behind Teva Pharmaceutical Industries’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Teva Pharmaceutical Industries’s data sources below and access millions more through our Disclosure Search.
Insights into Teva Pharmaceutical Industries's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Teva Pharmaceutical Industries amounted to 581,573 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Teva Pharmaceutical Industries decreased by 1.65%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
Teva Pharmaceutical Industries's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Teva Pharmaceutical Industries's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Teva Pharmaceutical Industries were 243,603 metric tons of CO₂ equivalent (tCO₂e). a
Has Teva Pharmaceutical Industries reduced its Scope 1 emissions over time?
Since 2018, Teva Pharmaceutical Industries's Scope 1 emissions have decreased by 34.62%, reflecting a declining long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2023), Teva Pharmaceutical Industries's Scope 1 emissions remained relatively stable, indicating that Teva Pharmaceutical Industries's emissions have plateaued with no significant change in its operational footprint. a
What are Teva Pharmaceutical Industries's Scope 2 emissions?
In 2024, Teva Pharmaceutical Industries reported Scope 2 greenhouse gas (GHG) emissions of 218,504 tCO₂e using the market-based method and 337,970 tCO₂e using the location-based method. a
Has Teva Pharmaceutical Industries reduced its Scope 2 emissions over time?
Compared to the previous year (2023), Teva Pharmaceutical Industries's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Teva Pharmaceutical Industries 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does Teva Pharmaceutical Industries use for Scope 2 reporting?
In 2024, Teva Pharmaceutical Industries reported its Scope 2 emissions using the market-based method and using the location-based method. a
Teva Pharmaceutical Industries's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Teva Pharmaceutical Industries's Value Chain Emissions
In 2024, Teva Pharmaceutical Industries reported 4,066,116 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2024 disclosure of Teva Pharmaceutical Industries includes a breakdown across 13 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
Teva Pharmaceutical Industries's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Teva Pharmaceutical Industries's Scope 3 emissions?
In 2024, Teva Pharmaceutical Industries reported total Scope 3 emissions of 4,066,116 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 68.62% of these emissions originated from upstream activities such as purchased goods and capital goods, while 31.38% came from downstream activities like product use, distribution, and end-of-life treatment. a
Compared to the previous year (2023), Teva Pharmaceutical Industries's Scope 3 emissions remained relatively stable, indicating that Teva Pharmaceutical Industries 's emissions have plateaued with no significant change in its value chain footprint. a
What categories of Scope 3 emissions does Teva Pharmaceutical Industries disclose?
In 2024, Teva Pharmaceutical Industries reported emissions for 13 out of the 15 Scope 3 categories defined by the GHG Protocol. a
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Teva Pharmaceutical Industries's Scope 3 emissions?
In 2024, the largest contributors to Teva Pharmaceutical Industries's Scope 3 emissions were: a
- Purchased Goods and Services (Cat. 1): 2,464,952 tCO₂e (60.62%)
- Use of Sold Products (Cat. 11): 754,046 tCO₂e (18.54%)
- End-of-Life Treatment of Sold Products (Cat. 12): 470,586 tCO₂e (11.57%)
Teva Pharmaceutical Industries's Scope 3 Emissions by Categories
Insights into Teva Pharmaceutical Industries’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Teva Pharmaceutical Industries reported Scope 1 greenhouse gas (GHG) emissions of 243,603 tCO₂e and total revenues of USD 16,544 millions. This translates into an emissions intensity of 14.72 tCO₂e per millions USD. a
Teva Pharmaceutical Industries's Scope 1 Emissions Intensity Compared to Peers
How does Teva Pharmaceutical Industries's GHG emissions intensity compare to its peers?
In 2024, Teva Pharmaceutical Industries reported a Scope 1 emissions intensity of 14.72 tCO₂e per millions USD. Compared to the peer group median of 12.6 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Teva Pharmaceutical Industries rank on GHG emissions intensity within its industry?
In 2024, Teva Pharmaceutical Industries ranked 12 out of 21 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Teva Pharmaceutical Industries is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a
Insights into Teva Pharmaceutical Industries's Total Carbon Footprint
In 2024, Teva Pharmaceutical Industries reported a total carbon footprint of 4,647,689 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 5.37% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output. a
The largest contributor to Teva Pharmaceutical Industries's total carbon footprint was Scope 3 emissions, accounting for 87.49% of the company's total carbon footprint, followed by Scope 2 emissions at 7.27%. a